Efinaconazole (Jublia®) SynthesisEssential intermediate for the synthesis of Efinaconazole, a breakthrough triazole antifungal agent for onychomycosis treatment.
Antifungal Drug Development • Key building block for efinaconazole synthesis • Used in triazole antifungal R&D programs • Critical for onychomycosis treatment formulations • Supporting next-generation antifungal research
Pharmaceutical Manufacturing • API intermediate production • Quality control reference standards • ANDA filing support materials • Pharmaceutical R&D applications
Research & Development • Medicinal chemistry research • Drug discovery programs • Pharmacological studies
|